Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/kead313 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comment on: Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis.
Rheumatology (Oxford)
December 2023
Kingston Health Sciences Center, Kingston, ON, Canada.
Comment on: Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis-caution is key in interpreting retrospective data: Reply.
Rheumatology (Oxford)
December 2023
Department of Dermatology and Venereology, University Hospital Cologne, Cologne, Germany.
Anti-acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
Am J Respir Crit Care Med
November 2022
University of Birmingham Birmingham, United Kingdom.
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply.
Lancet Respir Med
September 2016
Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg- Essen, Essen, Germany.
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution.
Lancet Respir Med
September 2016
Box 356175, Center for Interstitial Lung Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, USA. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!